| Intrinsic Valuation of: JBHT | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 6 | Market Cap | $25B | |||||
| 2021 | - | - (-) | P/E Ratio | 41 | Total Asset | $8B | |||||
| 2022 | $236M | - (-) | Net Income | $598M | Total Debt | $767M | |||||
| 2023 | $-118M | -149.9% (-157.6%) | EBITDA | $2B | Total Liab | $4B | |||||
| 2024 | $618M | 624.4% (656.6%) | Opr Margin | 7.21 | Debt/Equity | 0.22 | |||||
| 2025 | $948M | 53.4% (54.5%) | PreTax Margin | 6.58 | BV/Share | 36 | |||||
| 5Y Average FCF | $421M | 15.0% (184.5%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 10.46% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (15.0%) | ||||||||||
| 2026 | $970M | MBG Intrinsic Value | $58 | ||||||||
| 2027 | $1B | ||||||||||
| 2028 | $1B | ||||||||||
| 2029 | $1B | ||||||||||
| 2030 | $1B | ||||||||||
| 2031 | $1B | ||||||||||
| Terminal Value | $18B | Net Worth/Share | $38 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $15B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $17M | $150 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $767M | WACC | 8.5% | 181 | 192 | 205 | 220 | 238 | |||
| Equity Value | $14B | 9.5% | 157 | 165 | 174 | 184 | 196 | ||||
| Shares Outstanding | 94,299,203 | 10.5% | 138 | 144 | 150 | 158 | 166 | ||||
| 11.5% | 123 | 127 | 132 | 138 | 144 | ||||||
| DCF Intrinsic Value | $150 | 12.5% | 110 | 114 | 118 | 122 | 127 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||